Humoral responses to SARS-CoV2 in children

Humoral responses to SARS-CoV2 in children - COVID KIDS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52392

Enrollment

700

Registered

2020-04-02

Start date

2020-04-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease COVID-19

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: All children younger than 18 years of age that have blood drawn for normal/standard medical care in the emergency room, hospital ward or outpatient clinic of a participating hospital

Exclusion criteria

Exclusion criteria: No written informed consent from parents/ guardians or eligible child older than 12 years of age.

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: IgG, IgM, IgA and total neutralizing antibodies against SARS-CoV2 in blood and secretory IgA levels against SARS-CoV2 in saliva from all participants	—

Countries

Netherlands

Outcome results